Counteracting Drug-Induced Obesity Using GLP-1 Agonists
The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
27.06.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention describes administering a GLP-1 agonist to treat obesity caused by the administration of an obesity-inducing drug. |
---|---|
Bibliography: | Application Number: US201313776839 |